After Japanese Takeda’s acquisition of Millennium Pharmaceuticals Inc, the Cambridge, Massachusetts-based biotech’s top blood cancer drug Velcade draws new attention. Comprehensive data on market-leading Velcade for Injection for the treatment of multiple myeloma